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Viral Diseases and Human Evolution
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The interaction of  man with viral agents was possibly a key factor shaping human evolution, culture
and civilization from its outset.  Evidence of the effect of disease, since the early stages of human specia-
tion, through pre-historical times to the present suggest that the types of viruses associated with man
changed in time. As human populations progressed technologically, they grew in numbers and density.
As  a consequence different viruses found suitable conditions to thrive and establish long-lasting asso-
ciations with man. Although not all viral agents cause disease and some may in fact be considered
beneficial, the present situation of overpopulation, poverty and ecological inbalance may have devas-
tating effets on human progress.  Recently emerged diseases causing massive pandemics (eg., HIV-1
and HCV, dengue, etc.) are becoming formidable challenges, which may have a direct impact on the fate
of our species.
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THE EVOLUTIONARY BIOLOGY OF DISEASE
The astonishing development of molecular and
cell biology in recent years made possible a de-
tailed study of the molecular genetics of host-para-
site assemblages using the methodology of popu-
lation genetics, molecular systematics, molecular
epidemiology, etc. (Nei 1987, Hillis & Moritz
1990, Li 1997, Page & Holmes 1998). All these
methodologies benefited from the Darwinian evo-
lutionary thinking as an integrative framework
(Maynard-Smith 1989, Brooks & McLenann 1991,
Gillespie 1991, Mayr 1994, Takahata 1994).  Evo-
lution deals with the change of genetic diversity in
time and provides for an explanatory basis of cru-
cial biological phenomena and processes
(Dobzansky 1970). Due to its size and nature, vi-
ruses are directly studied at the cellular and sub-
cellular levels. Therefore, virology has also been a
major beneficiary of the evolutionary approach,
which has recently started to renovate biomedical
sciences (for a comprehensive review see Stearns
1999). A key concept is that, along with much of
each lineage’s own history, some of the history of
virus-host escalation (“arms race”) is kept in the
genetic make-up of both contenders (i.e., Red
Queen hypothesis, Van Valen 1973). This comes
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handy when dealing with situations where not
much is known about a given virus, either because
it was recently discovered, or because it just re-
cently emerged or reemerged in humans.  In this
article a few aspects of the impact of viruses on
human evolution will be addressed.
THE IMPACT OF DISEASE FROM THE HUMAN
ORIGIN
The interaction of hosts and parasites may be a
key factor in evolution, to the extent that basic fea-
tures of biological systems such as the appearance
of sex, may be explained by it (for a review see
Hamilton et al. 1990). It is known that parasites
are important factors regulating geographical dis-
tribution and host population size and density (for
review and thorough mathematical treatment see
Anderson & May 1979a,b, 1991, May & Ander-
son 1983; for an alternative perspective on the is-
sue see Ewald 1994). It can also be postulated that
man has been subject to infectious diseases
throughout his evolutionary history (Fenner 1970,
McKeown 1988). Infectious diseases that impact
on man’s life history parameters certainly did help
creating further distinctions among the myriad of
cultural configurations and, eventually, the way
that many civilizations evolved.
Going back in evolutionary time, we still see
evidence of the effect of disease in human evolu-
tion. The major histocompatibility complex (MHC)
of humans and other primates constitute a
multigene family which codes for proteins involved
in tissue compatibility and immunological defense.
Ayala et al. (1995) looked at the genetic diversity
in the MHC array of genetic loci. Their interest
was to estimate which polymorphism humans do
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share with chimpanzees and from it, the amount of
polymorphism that was passed along from a puta-
tive ancestral species to us. Their work invites the
conclusion that human speciation took place while
maximizing the maintenance of the preexisting
MHC polymorphism. Since MHC polymorphism
does increase resistance to disease (Hill et al. 1991,
1992) it may be assumed that significant selective
advantage was to be gained from keeping diver-
sity at these loci during early human evolution. At
least in part, this selective advantage had to be con-
sequence of disease. Additionally, the persistence
of MHC polymorphism during millions of years
had interesting implications in the demographics
of early man, since they implied that the size of
the initial human effective population size (Ne) had
to be 100 thousand individuals or more (Ayala et
al. 1995).
THE DIASPORA
Population genetics does suggest that the mini-
mal population size of early man was under check
by diseases. However, much more information is
needed to unravel what the impact of disease was
on shaping mankind, both biologically and socio-
culturally, from its onset until the recent recorded
historical times (Black 1975, McNeill 1993).
McNeill (1993) argued that when man left his
cradle in tropical Africa around 50 to 100 thou-
sand years before present (YBP), it left behind all
but a few infestations and infections to which it
had been exposed previously. Hare 1967, apud
Black 1975, argued that the small size of prehis-
toric human communities would require that patho-
gens had to have the ability to multiply on alterna-
tive hosts or cause persistent infections in order to
maintain lasting associations with man.
It is conceivable that when man moved out of
Africa into more temperate climates, a significant
shift took place on the types of challenges from
disease it was exposed to. During the dispersal
through all regions of the Earth (with the excep-
tion of a few islands), pathogens capable of caus-
ing persistent infections were possibly carried
along. Conversely, pathogens requiring alternative
hosts were purged once man left the geographical
area of their alternative hosts and vectors. With the
exception made for the couple last centuries, hu-
man historical records on specific diseases are scant
and fragmentary, and do not allow a precise deter-
mination of the causative agents (McKeown 1988).
In some instances paleopathologists were able to
identify certain diseases that leave lesions in bones
of primitive man, such as tuberculosis. Yet this
approach does not suit the study of several diseases
manifested only on soft tissues (Black 1975). At
best, descriptive methods such as serology may
provide identification of a disease agent and given
optimal conditions, also inform on disease preva-
lence and incidence. For example, serological tech-
niques introduced early in the 20th century allowed
retrospective studies of seroprevalence and inci-
dence in primitive societies (which may reflect the
conditions of early man) and modern societies.
These techniques provided not only fast identifi-
cation of pathogens, even after clearance from the
human host, but also their geographic distribution
and some rough estimate of their genetic diversity
and taxonomy. They also informed on whether a
pathogen may cause recurrent disease, such as in
those kept on alternative hosts with populations
way larger than man’s, since the proportion of
seropositives increase with age (e.g., arboviruses
and toxoplasmosis). Alternatively, age structuring
of seropositivity in a community inform us on lev-
els of endemicity or, whether pathogen is latent,
sporadic or has recently being introduced (Black
1975). Until today serology remains a practical and
useful basic research and clinical technique. Nev-
ertheless, it may not be effective to gauge the
amount of genetic variation directly caused by host-
parasite interactions and therefore precludes a bet-
ter understanding of the entailed evolutionary pro-
cess.
Nowadays, modern genotyping technologies
are giving considerable thrust to phylogenetic epi-
demiology of viruses, followed by the hallmark
improvement of nucleic acid amplification attained
by polymerase chain reaction (PCR) (Mullis &
Faloona 1987), thereby providing a potentially fast
and easy assess to virus genetic information.
HUMAN VIRUSES: ANCIENT AND NEW ASSO-
CIATIONS
Emerging or reemerging viruses are “new” dis-
eases, which got our attention due to the fact that
they may be associated with epidemic diseases of
varying degrees of morbidity and mortality (Morse
1993, 1994). However, in several instances, it is
possible that viruses may have crossed the specie’s
barrier recently, and started to propagate in explo-
sive ways in the absence of known or proven causal
association with manifested diseases. Hepatitis G
virus being an example of the former instance
(Pinho et al. 1999) and perhaps some human
circoviruses (e.g., transfusion transmitted virus,
TTV) of the latter.
In any case, it is possible that humans did not
have many of the “modern” diseases such as
measles, influenza, dengue, etc. until the Neolithic
period, possibly because then the human popula-
tion size and density were not enough to maintain
sustained epidemics (Black 1975).  As mentioned
above, it is evident that before Neolithic times, vi-
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ruses capable to establish long term persistent in-
fections in individuals had better chance to be
maintained in human populations and be dispersed
along with man. Among others, papilomaviruses,
herpesviruses, hepatitis B and some retroviruses
may constitute well studied examples of such long-
term type of association. Papilomaviruses (HPV)
are slow evolving DNA viruses which may cause
persistent infections in humans. Its long lasting
association with humans was investigated by Ber-
nard (Chan et al. 1992, Ho et al. 1993, Ong et al.
1993). They presented molecular phylogenies
which support the hypothesis that HPV came out
of Africa and coevolved with distinct human eth-
nic groups ever since. Herpes are also slow evolv-
ing DNA viruses with large genomes (White &
Fenner 1986).  Herpes viruses were shown to co-
evolve with distinct vertebrate lineages, possibly
since the Devonian (McGeogh et al. 1995). More-
over, several present vertebrate lineages have their
own “type” of herpes virus, which does not appear
to have the capability to move across its hosts spe-
cies barriers.  Independent on whether they were
introduced by Europeans or not, given the charac-
teristics of its biology and evolutionary history, it
is not surprising that three different herpes related
viruses, namely, herpes simplex, Epstein-Barr and
cytomegalovirus, along with hepatitis B (which
also causes persistent infections) where found to
be endemic in isolated primitive societies in the
Amazon basin (reviewed by Black 1975). Hepati-
tis B viruses were found in ducks, woodchucks,
squirrels and primates, suggesting a possible dis-
tant zoonotic origin for this virus as well (Takahashi
et al. 2000), which could explain its endemic state
in isolated Amazonian primitive societies.
 Another interesting but potentially more com-
plicated example is human T cell leukemia/lym-
phoma virus (HTLV) (Poiesz et al. 1980). The
HTLV-1 also causes persistent infections in hu-
mans and the adjacency patterns in molecular phy-
logenies suggest that this virus is more related to
the simian and primate T lymphotropic virus
(STLV-1) isolated from Old World apes and mon-
keys in Africa (but apparently not from New World
monkeys), than to HTLV-2, which also infects
humans (for a review on the origin of HTLVs see
Gessain & Mahieux 1999). On the other hand, the
HTLV-2 is found among several Indian popula-
tions throughout the Americas. As a consequence
of this, it is called “Paleo-Amerindian” strain and
it appears to be related to Asian isolates of STLV-
1.  Nevertheless, the Asian origin of HTLV-2 is
more obscure, since it was also found in several
places in Africa and the molecular phylogenies of
HTLV and STLV point to several independent in-
stances of virus exchanges among primate species,
including man (Gessain & Mahieux 1999). The
viruses we just mentioned above may exemplify
strategies which may minimize morbidity and
mortality and maximize viral survival at low host
population density and numbers, yet we should
avoid making sweeping generalizations on the is-
sue of the evolution of virulence (for a review see
Stearns 1999).
ENDOGENOUS RETROVIRUSES AND HUMAN
EVOLUTION
Endogenous retroviruses (ERV) were until re-
cently considered as part of “junk DNA”. Yet, by
being able to amplify their copy number by dupli-
cation and by being transmitted as Mendelian traits,
they could have influenced the differences of ge-
nome size (C-value) observed among species with
similar coding sequences (Lohman & Bjornson
1996). Moreover, current data may indicate other
relevant biological roles. The reason why so many
of these elements lurk in our genome could entail
some potential trade-off. In order to postulate this,
a selective advantage for the abundance of exog-
enous retroviruses is needed. In fact, several in-
stances where adaptive advantage may be postu-
lated can be found.
A common characteristic of ERVs is the abil-
ity to generate multiple copies that can be integrated
randomly or in clusters along the host DNA and at
the sites of integration short repeats are created.
Because ERV are involved in recombination and
duplication events, they make possible gene du-
plication, allele diversity and polymorphism. This
process probably influenced the level of diversity
at polymorphic human genes, like MHC. Indeed,
several HERV and HERV long terminal repeats
have been found in MHC class II genes (Andersson
et al. 1998); thereby, suggesting a possible benefi-
cial role by increasing and maintaining allele poly-
morphism in this important gene family.
However, an intriguing potential impact of
ERV on human evolution is to be appreciated un-
der our recent understanding of gestation, brought
by contemporary Darwinian thought. Following
embryo implantation, placental macrophages will
get in close contact with embryonic tissues, since
the embryo has a distinct genetic make-up from
that of the mother (Haig 1999). This genetic con-
flict can lead to the immune rejection of the em-
bryo by the mother’s immune system (as a matter
of fact, most natural terminations take place very
early during embryo formation). Certainly, it may
also be related to several of the complications com-
monly observed during pregnancy.
A Darwinian view of the genetic conflict on
pregnancy may provide not only satisfactory ex-
planation for several common hardships encoun-
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tered during pregnancy, but it may also suggest
another evolutionary trade-off between ERVs and
humans. HERV-K10 and murine ERV transcripts
expression are highly responsive to steroid hor-
mones (Patience et al. 1997, Patience 1999), while
high levels of ERV gene products are usually ob-
served in primate placental (syncytiotrophoblastic)
and embryonic cells (trophoblasts) (Boyd et al.
1993, Andersson et al. 1998). Therefore, it could
be postulated that ERV gene expression could pro-
vide a transient immunosuppression early during
pregnancy, which might be required to avoid em-
bryo immune clearance (Villareal 1997).
The hypothesis of a transient immunosuppres-
sion during primate syncytiotrophoblast differen-
tiation offers interesting clues of a possible sig-
nificant adaptive advantage provided by endog-
enous retrovirus to the evolution of placental mam-
mals. That is, human infection by ERVs may pro-
vide the temporary immune suppression crucial to
embryo survival during early stages of pregnancy.
Ultimately, it may counteract potential genetic con-
flict and thus may have played a role towards ex-
pansion of the genetic plasticity of human species.
THE AGRICULTURAL REVOLUTION IN NEOLITHIC:
NEW DISEASES
Pathogens infecting primitive small isolated
communities had to find ways (e.g. alternate host
reservoirs, vertical transmission, persistence or la-
tency, etc.) to keep alive, since the levels of sus-
ceptible human hosts during outbreaks would drop
bellow that required to avoid the pathogen popu-
lation to die out. Candidate viruses that possibly
thrived since the agricultural revolution in the
Neolithic up to recent historical times (when man
established large-enough communities), were
mainly those causing acute transient infections,
such as respiratory viruses, measles, smallpox, etc.
Accounts of the patterns of disease emergence in
history consider the fact that, recently in evolu-
tionary time, several human groups moved away
from a hunter-gatherer stage by starting more com-
plex agricultural practices, which entailed bigger
communities living in longer lasting settlements
(Black 1975, McKeown 1988, McNeill 1993).
This new human predicament had unforeseen
ecological consequences, however. Besides eco-
logical degradation, due to unsustainable economic
practices and inadequate cultural configurations,
another significant trade off was the inviting of new
types of diseases. Given the increase in density and
size of human communities, some pathogens
started to find adequate conditions to establish last-
ing associations with man. Pests and other mas-
sive epidemics in historical time are possibly ex-
amples of this (McKeown 1988, McNeill 1993).
VIRAL DISEASES IN THE HISTORICAL PAST
Although we have good examples of viruses
that reflect human history, the possible elucidation
of the origin of most group of viruses, based on
the biogeographical distribution of its genetic di-
versity, was made complicated by the increasing
in the interconnections among human populations.
The same could be said for almost any other known
disease of the present. This was caused by the con-
siderable exchange and movement of populations
between the New and Old World, which took place
since the outset of transoceanic navigations in the
16th century.
In fact, during the last few hundred years, due
to this increasing mobility of humans made pos-
sible by transoceanic navigation and swift trans-
continental migrations, viral diseases previously
confined to specific geographical locations were
able to spread widely, such as several arboviruses
(e.g., dengue, yellow fever, etc.). The types of vi-
ruses that were able to move into the swelling hu-
man population certainly included those that cause
lasting immunity among survivors including the
smallpox, mumps, measles, etc. McNeill (1993)
argued that once a local human population passed
a threshold size, it was able to acquire a “epide-
miological weapon” and that “the expanding en-
demically diseased society breaks down the politi-
cal and cultural structure of peripheral, disease in-
experienced populations”. Moreover, he argued
that disease would explain the small number of
civilizations in Eurasia and the fact that today Af-
rica still remains with Africans (with the excep-
tion of some land in the South).
One of the best examples of how a viral dis-
ease shaped history was the victory by barely van-
quished Spaniards under Cortez over a much more
formidable Aztec army in Mexico. The Aztecs,
despite reaching superiority in the battle ground,
causing the enemy to retreat, were hit by smallpox
and, as a consequence, were eventually subdued.
This event epitomized the fate of the indigenous
populations and presented a recurrent pattern which
lead to the repopulation of the Americas by dis-
ease-sturdy Europeans and Africans.
After the industrial revolution, man was able
to achieve enough control over several technologi-
cal processes, which caused mankind to mushroom
in numbers. Over the last 200 years, mankind grew
six times in size, reaching six billion by the end of
the 20th century (Zanotto et al. 1996b).  On top of
that, fast and efficient means of transportation of
humans and commodities across the planet, possi-
bly helped several lineages of zoonotic viruses
becoming mainly human diseases, bypassing a pre-
viously essential zoonotic cycle (Morse 1993,
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1994, Innis 1995). One of the most striking ex-
ample of emergent diseases is the virus causing
Aids (Gao et al. 1999). The HIV-1 has a  relatively
recent zoonotic origin. It is now believed that, af-
ter being associated with chimpanzees in Western
Africa (Corbet et al. 2000), the HIV in half a cen-
tury was able to infect millions of humans in the
entire world (Zhu et al. 1999, Korber et al. 2000,
for critical review on the pandemic see Gould
1993).
WHAT CAN WE LEARN FROM THE MOLECULAR
GENETICS OF VIRUSES
In recent years, implementations on sequenc-
ing technologies made possible fast and easy ac-
cess to the genetic sequence of pathogens, hence
extending the study of the genetic diversity of vi-
ruses. Indeed, PCR screening coupled with se-
quencing has opened the possibility to either de-
tect previously unknown but related members of
established viral families, or even to detect new
viruses. Sequence data was useful to the under-
standing of the ancestral relationships among vi-
ruses and to help address relevant questions about
their possible origins (Zanotto et al. 1996a, Kossida
et al. 2000). Moreover, sequence data of viral ge-
nomes, together with biogeographic information
on host, vectors and diseases, have become a use-
ful way to investigate dispersion mechanisms of
new and emergent viruses. Sequence analysis
showed a close relationship among the genetic
material of various endogenous retroviruses and
their natural hosts (Löwer et al. 1996, Herniou et
al. 1998), thereby clarifying important questions
concerning several aspects of the evolutionary bi-
ology of mammalian retroviruses. When not much
is known about a newly identified virus, such as
the hepatitis G virus, molecular phylogenies may
help identifying contagion mechanisms (Pinho et
al. 1999).  The origin of viruses causing outbreaks
may be readily identified by comparing their se-
quences with known references. This was the case
of the Rift Valley Fever virus (RVFV) causing a
recent massive outbreak in Kenya (Sall et al. 1998),
or the unexpected appearance of the West Nile
flavivirus in New York City last year (Lanciotti et
al. 1999).
Molecular phylogenies may also help under-
standing a few interesting features of the life his-
tory of viruses, since they may represent the pro-
cess of generation, loss and maintenance of the
genetic diversity along its branches. Moreover,
trees were shown to be explicit representation of
gene substitution processes and were useful for
estimating the selection coefficient of specific al-
leles in the nef gene of HIV-1 (Zanotto et al. 1999).
Hepatitis C virus was identified almost ten years
ago (Choo et al. 1989). Currently, it infects an es-
timated amount of 170 million people worldwide,
yet despite a lack of previous records of the dis-
ease, we can estimate via the shape of phyloge-
netic trees, possible times when it entered the hu-
man population (Holmes 1996). On another in-
stance, distinctions in the biology of tick- and
mosquito-borne flaviviruses were also made ap-
parent due to characteristics of their phylogenetic
trees. Tick-borne encephalitis (TBE) viruses have
a highly asymmetric and pectinated phylogeny in-
dicative of a clinal distribution (that is, a genetic-
geographic continuum) over much of Central and
Western Europe. This possibly reflects the disper-
sion of the vector species (Zanotto et al. 1995).
Mosquito borne flaviviruses, on their turn, are cos-
mopolitan due to the worldwide distribution of the
mosquito vector species. They also show molecu-
lar phylogenies that reflect their recent increasing
interaction with the human population. Dengue
viruses causing the current pandemics, appear to
have been subjected to a recent increase in its ge-
netic diversity. This can be inferred by phyloge-
netic trees constructed on the sequence data of their
envelope gene. Those trees showed few ancestral
lineages but revealed a recent exponential increase
in the number of lineages (Zanotto et al. 1996b).
This was explained merely by the explosive hu-
man population growth during the last 200 years
(Zanotto et al. 1996b, Holland 1996). Molecular
phylogenies may also provide means of mapping
specific amino acid replacements during the suc-
cession of endemic influenza strains, possibly
caused by the immune selection of the human popu-
lations (Fitch et al. 1991). They were also used to
elucidate transmission webs of HIV-1 in epidemic
clusters and support forensic arguments about HIV-
1 transmission cases (Holmes et al. 1993).
Several new developments in population ge-
netics applied to the study of viruses, promise to
change the field in further dramatic ways.  Viruses
are now been used as models for evolutionary bi-
ology in experimental evolutionary work, since
empirically generated known molecular phylog-
enies of viruses have the potential to enhance in-
ferential methodology (Hillis et al. 1992). More-
over, given the speed of some viral populational
processes and technical convenience (millions of
individual viruses replicating very fast in millili-
ter-sized flasks), several aspects of classical evo-
lutionary models are being tested by using viruses
(Burch & Chao 1999). The long-lasting debate on
selectionism and neutralism (Gillespie 1991,
Golding 1994, Kimura 1994, Hey 1999) may also
see considerable progress, due to the use of viruses
as experimental models (Leigh Brown 1997,
Rouzine & Coffin 1999a,b, Zanotto et al. 1999). It
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is fair to postulate that viruses may have a similar
impact on evolutionary biology in the 21st cen-
tury, as fruit flies had during the early 20th cen-
tury.
FUTURE PERSPECTIVES: MAN IN BALANCE
Our understanding of emerging and reemerg-
ing viruses from an evolutionary perspective of-
fers clear directions to follow.  Firstly, if we seri-
ously plan to come up with efficient and reason-
able control strategies, an international concerted
effort on a thorough survey of the genetic diver-
sity, in time and space of viruses is a must. This
will also help understanding several processes that
take place at the molecular level in a comparative
context (Harvey & Pagel 1991).  Secondly, more
emphasis on multidisciplinary sciences is needed.
Molecular biology and systematics, bioinformatics,
data mining and analysis, etc., all are becoming
considerably sophisticated lately. However, these
endeavors will be more effective only when de-
veloped and applied on integrative research pro-
grams with strong empirical backing.
It is common sense to understand human dis-
ease as caused by man himself. Among its key fac-
tors we can cite: ecological degradation, poverty
and human conflict. Even when massive wealth
and technological progress takes place among
some, disease persists for most. Technically, this
can be explained by historical (cultural) inherit-
ance and huge differences among the many
civilizatory stages of present day societies (many
of which may not survive under a single or im-
posed paradigm of development). However, the
Darwinian understanding of our biological origin
and constitutive traits begs for a critical reflection
upon our future.
Ultimately, the present appalling state of affairs
for billions of human beings can only be surpassed
by compassionate understanding of our collective
human condition and fate, at the expense of blind
short-term circumstantial advantages. Hepatitis C
and HIV-1 are glaring proofs that disease knows
no national borders. Solutions for the problems of
diseased poor societies are not only the most hu-
mane universal priority but, possibly also a guar-
antee for the future generations and ultimately for
the survival of man as a species.
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